Akari Therapeutics PLC (AKTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $15.54M
Last updated: Nov 17, 2026 at 10:59 AM ET
Akari Therapeutics PLC (AKTX) Earnings: Report Dates and Results
Akari Therapeutics (AKTX) is expected to report earnings on Mar 29, 2027. In the quarter ended Jun 30, 2026, Akari Therapeutics reported EPS of -$2.69, below the -$1.04 estimate. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
AKTX has an expected report date of Mar 29, 2027.
Earnings History
Of the 22 quarters below that had an estimate, AKTX beat 11, missed 8 and matched 3. The widest gap in the table came in the quarter ended Dec 31, 2019, when EPS landed 178.57% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$2.69 | -$1.04 | -$1.04 - -$1.04 | -158.47% | Miss | N/A | 1 | 1 up, 0 down | Aug 13, 2026 |
| Mar 31, 2026 | -$9.72 | -$0.66 | N/A | N/A | N/A | N/A | 1 | 0 up, 0 down | Apr 7, 2026 |
| Sep 30, 2025 | -$1.06 | -$4.40 | -$4.40 - -$4.40 | +75.91% | Beat | N/A | 1 | 0 up, 0 down | Nov 13, 2025 |
| Jun 30, 2025 | -$3.92 | -$4.80 | -$4.80 - -$4.80 | +18.33% | Beat | N/A | 1 | 0 up, 0 down | Aug 13, 2025 |
| Mar 31, 2025 | -$0.19 | -$1.00 | N/A | +81.00% | Beat | N/A | N/A | N/A | Apr 14, 2025 |
| Sep 30, 2024 | -$9.59 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 18, 2024 |
| Jun 30, 2024 | -$0.80 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Aug 18, 2024 |
| Mar 31, 2024 | -$0.83 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | May 14, 2024 |
| Dec 31, 2023 | -$2.40 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Mar 29, 2024 |
| Sep 30, 2023 | Not reported | -$0.60 | N/A | N/A | Not reported | N/A | N/A | 0 up, 0 down | Oct 3, 2023 |
| Jun 30, 2023 | Not reported | -$40.00 | N/A | N/A | Not reported | N/A | 1 | 0 up, 0 down | Jul 19, 2023 |
| Mar 31, 2023 | -$0.08 | -$0.07 | N/A | -14.29% | Miss | N/A | N/A | N/A | May 1, 2023 |
| Dec 31, 2022 | -$0.08 | -$0.07 | N/A | -14.29% | Miss | N/A | N/A | N/A | Mar 9, 2023 |
| Sep 30, 2022 | -$0.04 | -$0.04 | N/A | 0.00% | In line | N/A | N/A | N/A | Dec 30, 2022 |
| Jun 30, 2022 | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 27, 2022 |
| Mar 31, 2022 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 16, 2022 |
| Sep 30, 2021 | -$0.03 | N/A | N/A | N/A | N/A | -172.1% | N/A | 0 up, 0 down | Dec 3, 2021 |
| Jun 30, 2021 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Sep 22, 2021 |
| Mar 31, 2021 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 20, 2021 |
| Sep 30, 2020 | $0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 11, 2020 |
| Jun 30, 2020 | -$2.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 1, 2020 |
| Mar 31, 2020 | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 29, 2020 |
| Dec 31, 2019 | -$0.39 | -$0.14 | -$0.29 - $0.00 | -178.57% | Miss | N/A | 2 | N/A | Mar 31, 2020 |
| Sep 30, 2019 | -$0.14 | -$0.12 | -$0.24 - $0.00 | -16.67% | Miss | N/A | 2 | N/A | Nov 4, 2019 |
| Jun 30, 2019 | -$0.25 | -$0.13 | -$0.27 - $0.00 | -92.31% | Miss | N/A | 2 | N/A | Aug 29, 2019 |
| Mar 31, 2019 | -$0.15 | -$40.00 | -$80.00 - $0.00 | +99.63% | Beat | N/A | 2 | N/A | Apr 23, 2019 |
| Dec 31, 2018 | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 18, 2019 |
| Sep 30, 2018 | -$0.24 | -$8.00 | N/A | +97.06% | Beat | N/A | N/A | N/A | Nov 15, 2018 |
| Jun 30, 2018 | -$0.53 | -$0.40 | -$0.58 - -$0.30 | -32.50% | Miss | N/A | 2 | N/A | Aug 17, 2018 |
| Mar 31, 2018 | -$0.58 | -$0.72 | N/A | +19.44% | Beat | N/A | 2 | N/A | May 30, 2018 |
| Dec 31, 2017 | -$8.00 | -$8.00 | N/A | 0.00% | In line | N/A | 2 | N/A | Mar 21, 2018 |
| Sep 30, 2017 | -$8.00 | -$8.00 | N/A | 0.00% | In line | N/A | 2 | N/A | Nov 13, 2017 |
| Jun 30, 2017 | -$0.03 | -$560.00 | N/A | +100.00% | Beat | N/A | 2 | N/A | Aug 10, 2017 |
| Mar 31, 2017 | -$8.00 | -$432.00 | -$608.00 - -$432.00 | +98.15% | Beat | N/A | 3 | N/A | May 15, 2017 |
| Dec 31, 2016 | -$1.00 | -$0.83 | N/A | -20.48% | Miss | -284.4% | N/A | N/A | Mar 31, 2017 |
| Sep 30, 2016 | -$0.04 | -$664.00 | N/A | +99.99% | Beat | N/A | N/A | N/A | Nov 10, 2016 |
| Jun 30, 2016 | -$4.00 | -$808.00 | N/A | +99.50% | Beat | N/A | N/A | N/A | Aug 11, 2016 |
| Mar 31, 2016 | -$0.30 | -$1.01 | N/A | +70.30% | Beat | N/A | N/A | N/A | May 12, 2016 |
| Dec 31, 2015 | $0.54 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 23, 2016 |
| Sep 30, 2015 | -$6.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 23, 2015 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$16.47, after -$2.62 in the fiscal year ended Dec 31, 2022. It was -$478.85 for the year ended Dec 31, 2013, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$16.47 | N/A |
| Dec 31, 2022 | -$2.62 | N/A |
| Dec 31, 2019 | -$0.93 | N/A |
| Dec 31, 2018 | -$1.57 | N/A |
| Dec 31, 2017 | -$24.03 | N/A |
| Dec 31, 2016 | -$5.34 | N/A |
| Dec 31, 2015 | -$12.51 | N/A |
| Dec 31, 2013 | -$478.85 | N/A |
Frequently Asked Questions About AKTX
When is Akari Therapeutics's next earnings date?
Akari Therapeutics's next earnings report is expected for Mar 29, 2027.
Did AKTX beat earnings estimates last quarter?
No. Akari Therapeutics reported EPS of -$2.69 for the quarter ended Jun 30, 2026, below the -$1.04 estimate by 158.47%.
What EPS do analysts expect from AKTX next quarter?
The consensus EPS estimate for Akari Therapeutics for the quarter ending Dec 31, 2026 is -$0.94 from 4 analysts.
How often does AKTX beat earnings estimates?
Akari Therapeutics beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -23.80%.
AKTX pages: Overview, Earnings, Forecast, Financials, Competitors